Article
It is not all about BRCA: Cullin-Ring ubiquitin Ligases in ovarian cancer.
British journal of cancer - 6 Jan 2015
Carlucci A, D'Angiolella V
Abstract excerpt
Mutations in the BRCA1 and BRCA2 genes predispose individuals to the development of breast and ovarian cancers. As a result, biochemical functions of BRCA1 and BRCA2 proteins are being characterised in great detail. These studies have prompted the use of PARP inhibitors to treat BRCA1 and BRCA2-deficient ovarian cancers. This example of synthetic lethality represents a conceptual progress made recently in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
